US SEC Trading Suspension Halt Orders — March 06, 2026

06-03-2026

United States Antimony Corporation (UAMY) filed an 8-K on March 6, 2026, under Item 3.01 notifying of delisting or failure to satisfy a continued listing rule or standard, a material negative development for shareholders. The filing also furnishes Exhibit 99.1, a press release under Item 7.01 (Regulation FD Disclosure), which includes forward-looking statements on the company's plans and potential benefits from a joint venture. No financial metrics or period comparisons were provided.

• ·Filing items include 3.01 (Notice of Delisting/Failure to Satisfy Rule), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits).
• ·Exhibit 99.1 is a Press Release dated March 6, 2026, furnished but not deemed 'filed' under the Exchange Act.

06-03-2026

Traeger, Inc. (COOK) received NYSE notice on March 5, 2026, for non-compliance with continued listing standard Section 802.01C, as average closing stock price was below $1.00 over the 30 trading-day period ended March 4, 2026, but no immediate delisting occurs with a 6-month cure period provided. At a special stockholder meeting on March 2, 2026, shareholders overwhelmingly approved a reverse stock split (1-for-10 to 1-for-50 ratio, at board discretion) to help regain compliance. The company plans to evaluate options including the reverse split, with stock remaining listed and traded during the cure period.

• ·Stockholders also approved Proposal Two (adjournment if needed) with 124,726,243 votes for, 2,153,788 against, and 255,031 abstentions.
• ·Cure period compliance requires closing price >= $1.00 and 30-day average >= $1.00 on last trading day of any month within 6 months.
• ·No impact on business operations, SEC reporting, or debt obligations.

06-03-2026

Presurance Holdings, Inc. received a Nasdaq notice on March 3, 2026, stating non-compliance with the minimum bid price requirement under Rule 5550(a)(2), as its common stock (PRHI) closed below $1.00 per share for 30 consecutive business days. The company has 180 calendar days until August 31, 2026, to regain compliance by closing at or above $1.00 for 10 consecutive business days, potentially via a reverse stock split approved by shareholders in June 2025. Failure to comply risks delisting, with no assurance of success despite available options.

• ·Nasdaq Marketplace Rule 5550(a)(2) violated; Rule 5810(c)(3)(A) provides initial 180-day cure period.
• ·Board has authority to effect reverse stock split until June 3, 2026, if deemed in shareholders' best interests.
• ·Eligibility for second 180-day period requires meeting other Nasdaq Capital Market initial listing standards except bid price.

06-03-2026

Offerpad Solutions Inc. was notified by the NYSE on March 3, 2026, of non-compliance with Section 802.01C of the NYSE Listed Company Manual, as the average closing price of its Class A common stock (OPAD) was below $1.00 over a consecutive 30 trading-day period, triggering a potential delisting risk. The company stated its intent to cure the deficiency within a six-month period, potentially through a reverse stock split requiring stockholder approval at its next annual meeting, while its stock continues to trade on the NYSE subject to other listing standards. No immediate delisting will occur, but failure to regain compliance could lead to transfer to a lower market tier.

• ·Cure period: six months from March 3, 2026
• ·Compliance cure condition: closing share price of at least $1.00 and average of $1.00 over 30 trading days ending last day of any month during cure period
• ·Press release issued March 6, 2026 (Exhibit 99.1)
• ·Recent 10-K filed February 24, 2026, for year ended December 31, 2025

06-03-2026

Borealis Foods Inc. received a Nasdaq letter on March 2, 2026, accepting its compliance plan and granting a one-month extension until May 31, 2026, to hold its overdue annual shareholders' meeting required under Listing Rule 5620(a), following an initial non-compliance notice on January 12, 2026. The delay is attributed to the company's challenging financial condition, which has hindered its ability to convene the meeting. While the company intends to regain compliance, failure to do so risks a delisting notice and potential appeal process.

• ·Previous 8-K disclosure of non-compliance: January 16, 2026
• ·Company fiscal year end: December 31
• ·Securities listed: Common Shares (BRLS), Warrants (BRLSW) on Nasdaq Capital Market
• ·Former name: Oxus Acquisition Corp. (name change: March 23, 2021)

06-03-2026

On March 5, 2026, Jaguar Health, Inc. received a Nasdaq notice of non-compliance with Listing Rule 5550(a)(2) due to its common stock (JAGX) bid price closing below the $1.00 minimum for 30 consecutive business days. The company is ineligible for a compliance period under Rule 5810(c)(3)(A)(iv) because of prior reverse stock splits with a cumulative ratio of 250:1 or more. Jaguar intends to appeal by March 12, 2026, but there is no assurance of success or regaining compliance.

• ·Nasdaq Listing Rule 5550(a)(2): minimum $1.00 bid price requirement.
• ·Nasdaq Listing Rule 5810(c)(3)(A)(iv): ineligibility for compliance period due to reverse stock splits with cumulative ratio of 250 shares or more to one over prior two-year period.
• ·Appeal request due by March 12, 2026; timely appeal stays delisting pending hearing.

06-03-2026

Beyond Meat, Inc. received a Nasdaq deficiency notice on March 4, 2026, stating that its common stock (BYND) closing bid price was below the $1.00 minimum for 30 consecutive business days, violating Listing Rule 5450(a)(1). The Company has 180 calendar days until August 31, 2026, to regain compliance by achieving a $1.00 closing price for 10 consecutive business days, with no immediate impact on trading. While stockholders approved reverse stock split options on November 19, 2025, there is no assurance of compliance, potentially leading to transfer to Nasdaq Capital Market or delisting.

• ·Stock continues to trade on The Nasdaq Global Select Market under symbol BYND
• ·Stockholder special meeting on November 19, 2025, approved 30 alternate amendments to Restated Certificate of Incorporation for reverse stock split
• ·Proxy statement filed with SEC on October 17, 2025

06-03-2026

On March 6, 2026, Iveda Solutions, Inc. received a Nasdaq notice stating its common stock (IVDA) failed to maintain a $1 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has 180 calendar days until September 2, 2026, to regain compliance by achieving a $1 closing bid for 10 consecutive business days, with no immediate listing impact but potential delisting risk thereafter. Warrants (IVDAW) are also referenced as listed on Nasdaq.

• ·Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period.
• ·Company headquartered at 1744 S. Val Vista, Suite 213, Mesa, Arizona 85204.
• ·Appeal to Nasdaq Hearings Panel possible if delisting notice issued.

06-03-2026

Nerdy Inc. was notified by the NYSE on March 5, 2026, that it is not in compliance with continued listing criteria under Section 802.01C due to its Class A common stock's average closing price being less than $1.00 over a consecutive 30 trading-day period, posing a delisting risk. The company intends to cure the deficiency within a six-month period, potentially via a reverse stock split subject to stockholder approval at its 2027 annual meeting, while its stock continues to trade on the NYSE. As of December 31, 2025, the company reported $47.9M in cash and equivalents, stating ample liquidity to support operations and growth.

• ·Compliance cure possible if closing share price >= $1.00 and 30-day average >= $1.00 on last trading day of any month in six-month period.
• ·Notice does not impact business operations, SEC reporting, or term loan.
• ·Press release issued March 6, 2026, attached as Exhibit 99.1.